.png){kind=icon}
4T1-LUC2: Mouse Mammary Carcinoma
| Parameter | Information |
|---|---|
| Strain | BALB/c |
| Implant Type | Cells |
| Implant Location | Mammary Fat Pad |
| Time to Staging | 8 Days |
| Time to 750mm3 | 22 days |
| Td | 6 days |
(The above parameters are from one study. For further information on this cell line and other parameters, including different strains, vendors, implant type and location and/or standards of care, please contact Covance.)
***Please note that cell lines are not for sale and unavailable for purchase from Covance.***
Fill out our tumor models contact form to get started setting up your next preclinical study with us.
Histotype: Mammary/Breast
Tumor Line: Mouse
REF# 234B
Related Information:
- 4T1-luc2: An orthotopic mammary cancer odel to support novel immuno-oncology drug discovery
- Combined focal radiation and anti-mCTLA-4 antibody therapy modulates myeloid subset phospho-stat3 levels in the 4T1 tumor microenvironment, and results in tumor growth inhibition
- Focal radiation in the murine 4T1-luc2 mammary cancer model